Strong demand for dietary supplements and successful launches of dermatology and pain products helped Bayer Consumer Health to grow faster than the market in 2021. And the company is bullish about repeating this feat in 2022 with sales growth expected to be driven by cough and cold products and the US launch of Astepro Allergy following its switch last year.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?